John Evans
Chief executive officer of Beam Therapeutics, leading development of base editing therapies for genetic diseases including programs in alpha-1 antitrypsin deficiency and sickle cell disease.
Best podcasts with John Evans
Ranked by the Snipd community
Jan 12, 2026 • 10min
SF Healthcare Week: Beam's CEO John Evans shares an update on based editing for alpha-1 antitrypsin deficiency, sickle cell disease, and more
John Evans, CEO of Beam Therapeutics, shares exciting advancements in base editing therapies for genetic diseases. He discusses potential accelerated approval for alpha-1 antitrypsin deficiency, highlighting regulatory feedback and a focus on confirmatory trials measuring lung and liver outcomes. Evans explains the advantages of base editing over other methods, especially for sickle cell disease, and teases future targets for liver conditions. With innovative approaches to LNP delivery, he emphasizes the platform's potential for customizable solutions in genetic therapies.
Aug 18, 2023 • 1h 20min
John Evans: Dissecting Offshore Services w/ Subsea7 CEO
John Evans, CEO of Subsea 7, discusses the offshore space, success factors, the value chain, customer relationships, barriers of entry, future industry prospects, managing backlog, and misconceptions about Subsea7.
